ask="N/A"
ask_size="N/A"
average_daily_volume="697326"
bid="17.150"
bid_size="100"
book_value="7.600"
change="-0.125"
change_from_200_day_moving_average="-4.831"
change_from_50_day_moving_average="-0.205"
change_from_52_week_high="-14.705"
change_From_52_week_low="5.955"
change_in_percent="-0.571%"
close="21.775"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.860"
ebitda="-157.23M"
eps_estimate_current_year="-3.860"
eps_estimate_next_quarter="-0.990"
eps_estimate_next_year="-3.400"
ex_dividend_date="N/A"
float_shares="38576000"
high="21.800"
high_52_weeks="36.480"
last_trade_date="2/24/2017"
last_trade_price="21.775"
last_trade_size="14843"
last_trade_time="4:00pm"
low="19.050"
low_52_weeks="15.820"
market_capitalization="1.10B"
moving_average_200_day="26.606"
moving_average_50_day="21.980"
name="Alder BioPharmaceuticals
Inc."
notes="N/A"
one_year_target_price="41.250"
open="20.000"
pe_ratio="N/A"
peg_ratio="-0.240"
percent_change_from_200_day_moving_average="-18.157%"
percent_change_from_50_day_moving_average="-0.933%"
percent_change_from_52_week_high="-40.310%"
percent_change_from_52_week_low="+37.642%"
previous_close="21.900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.882"
price_per_sales="9769.618"
revenue="112999.00"
shares_outstanding="50409000"
short_ratio="11.520"
stock_exchange="NGM"
symbol="ALDR"
volume="1053563"
weeks_range_52="15.820 - 36.480"
